AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇿🇲
Xylometazoline Hydrochloride in Zambia
5 products registered with ZAMRA — 5 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| Xonase Nasal Drops Nasal drops | 254/085 | Bliss GVS Pharma Ltd | active | 13 Aug 2030 |
| Otrivin Adult spray Solution | 242/006 | GlaxoSmithKline Consumer Healthcare South Africa (Pty) Ltd | active | 11 Jul 2030 |
| Decon Nasal drops Nasal drop solution | 113/039 | Cadila Pharmaceuticals Limited | active | 28 May 2029 |
| Otrivin Nasal Spray Spray For Nasal Use | UNKNOWN-4df79f6e | GlaxoSmithKline South Africa (Pty) Ltd | active | 24 May 2029 |
| Otrivin Nasal Spray Spray For Nasal Use | UNKNOWN-57e56def | GlaxoSmithKline South Africa (Pty) Ltd | active | 24 May 2029 |
Xylometazoline Hydrochloride — ZAMRA Registration Details
ZAMRA (Zambia) has 5 registered products containing Xylometazoline Hydrochloride, of which 5 are currently active. Data is sourced directly from the official ZAMRA drug register and refreshed daily.
Track Xylometazoline Hydrochloride registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.